Regulación de la Expresión Génica; Hipoxia/genética; MicroARNs/genética; Factores de Transcripción/genética; Adaptación Fisiológica; Animales; Apoptosis; Epigénesis Genética; Humanos; Hipoxia/metabolismo; Hipoxia/fisiopatología; MicroARNs/agonistas; MicroARNs/antagonistas & inhibidores; MicroARNs/metabolismo; Oxígeno/farmacología; Transducción de Señal; Factores de Transcripción/metabolismo; Transcripción Genética

3' untranslated region; 3'UTR; Ago2; Argonaute 2; CCN5; CUL2; ChIP; DGCR8; DMNT; DNA methyltransferase; Di George syndrome critical region 8; E2F transcription factor 3; E2F3; Free radicals; HIF; HRE; HUVEC; Hypoxamir; Hypoxia; MicroRNA; NF-κB; ODD; PTM; ROS; TF; TNF receptor-associated factor 6; TRAF6; TWIST1; Twist-related protein 1; UPR; VHL; chromatin immunoprecipitation; cullin2; cysteine-rich 61/connective tissue growth factor/nephroblastoma overexpressed 5; human umbilical vein endothelial cell; hypoxia-inducible factor; hypoxia-responsive element; mTOR; mammalian target of rapamycin; miRISC; miRNA; miRNA-induced silencing complex; microRNA; nuclear factor-κB; oxygen-dependent domain; posttranslational modification; pre-miRNA; precursor miRNA; pri-miRNA; primary microRNA; reactive oxygen species; transcription factor; unfolded protein response; von Hippel-Lindau tumor suppressor protein